γ-ray induced hepatocarcinogenesis in p53-deficient mice

被引:0
作者
Kaizu, H
Cho, DZ
Matsuki, A
Ohkoshi, S
Nomoto, M
Asakura, H
机构
[1] Niigata Univ, Sch Med, Dept Internal Med 3, Niigata 9518122, Japan
[2] Niigata Univ, Sch Med, Dept Internal Med 2, Niigata 9518122, Japan
[3] Niigata Univ, Sch Med, Dept Surg 1, Niigata 9518122, Japan
关键词
p53; gamma-ray; hepatocellular carcinoma; thymic lymphoma;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Mutations in the p53 gene are frequent genetic alterations in human hepatocellular carcinoma (HCC), but, little is known of the molecular genetic changes that occur during murine hepatocarcinogenesis. Materials and Methods: To characterize the properties of constitutive p53 deficiency that contribute to fiver tumor development, a total of 168 Fl mice of two different strains (C3H, which are susceptible to hepatocarcinogenesis and MSM [Mus. M. molossinus] with a single null p53 allele) were exposed to a single 3-Gy dose of whole-body gamma-irradiation at 4 weeks of age and observed for a period of 360 days. The genotype of the mice and the p53 spectrum of the tumors were investigated by polymerase chain reaction (PCR) analysis. Results: Thirty-five gamma-ray-induced HCCs were obtained as a result of this experiment. 11 (40%) of the mice with liver tumor were wild-type for p53. All liver tumors examined retained the wild-type p53 allele, indicating that p53 itself may nor be a target for radiation-induced alteration. Only two p53-deficient mice in the liver tumor group developed thymic lymphomas. The p53-deficient mice showed no significant differences in the number, size, or growth rate of HCC or in the apparent development of HCC. Conclusions: These results indicate that p53 deficiency does not enhance the rate of development ol degree of malignancy of radiation-induced HCC in mice but may instead favor the development of multiple primary cancers.
引用
收藏
页码:1545 / 1549
页数:5
相关论文
共 14 条
[1]   Human/mouse homology relationships [J].
DeBry, RW ;
Seldin, MF .
GENOMICS, 1996, 33 (03) :337-351
[2]   SPONTANEOUS AND CARCINOGEN-INDUCED TUMORIGENESIS IN P53-DEFICIENT MICE [J].
HARVEY, M ;
MCARTHUR, MJ ;
MONTGOMERY, CA ;
BUTEL, JS ;
BRADLEY, A ;
DONEHOWER, LA .
NATURE GENETICS, 1993, 5 (03) :225-229
[3]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[4]   INFREQUENT P53 MUTATIONS IN 7,12-DIMETHYLBENZ[A]ANTHRACENE INDUCED MAMMARY-TUMORS IN BALB/C AND P53 HEMIZYGOTIC MICE [J].
JERRY, DJ ;
BUTEL, JS ;
DONEHOWER, LA ;
PAULSON, EJ ;
COCHRAN, C ;
WISEMAN, RW ;
MEDINA, D .
MOLECULAR CARCINOGENESIS, 1994, 9 (03) :175-183
[5]  
KASTAN MB, 1991, CANCER RES, V51, P6304
[6]   P53 MUTATIONS ARE ABSENT FROM CARCINOGEN-INDUCED MOUSE-LIVER TUMORS BUT OCCUR IN CELL-LINES ESTABLISHED FROM THESE TUMORS [J].
KRESS, S ;
KONIG, J ;
SCHWEIZER, J ;
LOHRKE, H ;
BAUERHOFMANN, R ;
SCHWARZ, M .
MOLECULAR CARCINOGENESIS, 1992, 6 (02) :148-158
[7]   CANCER - P53, GUARDIAN OF THE GENOME [J].
LANE, DP .
NATURE, 1992, 358 (6381) :15-16
[8]  
*LIV CANC STUD GRO, 1997, CLASSIFICATION PRIMA
[9]   THE MDM-2 ONCOGENE PRODUCT FORMS A COMPLEX WITH THE P53 PROTEIN AND INHIBITS P53-MEDIATED TRANSACTIVATION [J].
MOMAND, J ;
ZAMBETTI, GP ;
OLSON, DC ;
GEORGE, D ;
LEVINE, AJ .
CELL, 1992, 69 (07) :1237-1245
[10]   MUTATIONS IN THE P53 GENE OCCUR IN DIVERSE HUMAN-TUMOR TYPES [J].
NIGRO, JM ;
BAKER, SJ ;
PREISINGER, AC ;
JESSUP, JM ;
HOSTETTER, R ;
CLEARY, K ;
BIGNER, SH ;
DAVIDSON, N ;
BAYLIN, S ;
DEVILEE, P ;
GLOVER, T ;
COLLINS, FS ;
WESTON, A ;
MODALI, R ;
HARRIS, CC ;
VOGELSTEIN, B .
NATURE, 1989, 342 (6250) :705-708